Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24244| Title: | A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Antibiotics, Antineoplastic/*administration & dosage/adverse effects,Breast Neoplasms/*drug therapy,Disease-Free Survival,Drug Administration Schedule,Epirubicin/*administration & dosage/adverse effects,Female,Humans,Middle Aged,Survival Analysis,Treatment Outcome |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/24244 |
| ISSN: | 0923-7534 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/9496386 http://annonc.oxfordjournals.org/content/8/12/1213.full.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Fountzilas-1997-A randomized study o.pdf | 1.71 MB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
